Tag: CAD-1883
Novartis to acquire neuroscience company Cadent Therapeutics in $770m worth deal
Novartis acquisition of Cadent Therapeutics : Swiss pharma giant Novartis has agreed to acquire a US neuroscience company Cadent Therapeutics, in a deal worth up ... Read More